about
Quantification of homocysteine-related metabolites and the role of betaine-homocysteine S-methyltransferase in HepG2 cells.Validation and pharmacokinetic application of a high-performance liquid chromatographic technique for determining the concentrations of amodiaquine and its metabolite in plasma of patients treated with oral fixed-dose amodiaquine-artesunate combinatRhodopsin and Melanopsin Contributions to the Early Redilation Phase of the Post-Illumination Pupil Response (PIPR).Bioanalysis in drug discovery and development.Methodologic issues in the validation of putative biomarkers and surrogate endpoints in treatment evaluation for systemic lupus erythematosus.The role of acid-base imbalance in statin-induced myotoxicityBioanalytical method validation: An updated review.Quadrant Field Pupillometry Detects Melanopsin Dysfunction in Glaucoma Suspects and Early Glaucoma.Development and technical and clinical validation of a quantitative enzyme-linked immunosorbent assay for the detection of human antibodies to hepatitis B surface antigen in recipients of recombinant hepatitis B virus vaccineEnantioselective analysis of albendazole sulfoxide in cerebrospinal fluid by capillary electrophoresis.Evaluation of an isochronic study design for long-term frozen stability investigation of drugs in biological matrices.Plasma Cytochrome c Detection Using a Highly Sensitive Electrochemiluminescence Enzyme-Linked Immunosorbent Assay.Determination of lipoic acid in human urine by capillary zone electrophoresis.Voltammetric quantitation of nitazoxanide by glassy carbon electrode.Pharmacokinetics and bioequivalence evaluation of cyclobenzaprine tablets.Determination of RSD921 in human plasma by high-performance liquid chromatography-tandem mass spectrometry using tri-deuterated RSD921 as internal standard: application to a phase I clinical trial.Differential Pulse Adsorptive Stripping Voltammetric Determination of Zafirlukast in Pharmaceutical Formulations
P2860
Q34288550-DB2B8E4C-34BD-4EC2-AB4E-13FC8DB3DEA3Q35960735-B3D8B8E9-7106-433F-8F13-289458C2D4C5Q36109184-FA2C3890-B162-42CC-9176-DFC0ACD64B3AQ36855961-1275FA29-D861-4FBE-8C6F-1D9BD4DB2F7BQ37101364-16E09EDD-C513-4F82-A1CA-B9BD1244DE59Q37140174-5B43A498-F082-420A-B507-C55043602035Q38115536-93E60173-205B-407D-9ACD-AF4FAB842A13Q38821827-CC9AD56C-57B3-408C-966E-2A919DC1432CQ41808488-1E96A02C-9D55-4C0E-BD9F-E9DE5A04F806Q43758323-368F97CA-543C-432B-81A8-EFB2317B795AQ45428835-C854C471-4AE2-41E2-AA0E-7FC78F2619BDQ47094725-24D8083B-7F85-43AD-868B-F022FF415324Q48265469-E7DAF4F2-9C75-4042-BD58-DCBF0F867ECFQ50196667-DE92CA77-F8E3-4468-A777-4C4ACBA33E61Q51332376-1251CF0A-4C39-4143-A7F4-AD685356658AQ51340485-19E1F17E-8589-4D63-9798-283BB1F6612BQ58274531-10250371-5044-49EF-B41A-7E5CE936FEBE
P2860
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
A strategy for validation of bioanalytical methods.
@en
type
label
A strategy for validation of bioanalytical methods.
@en
prefLabel
A strategy for validation of bioanalytical methods.
@en
P2093
P1476
A strategy for validation of bioanalytical methods.
@en
P2093
P304
P356
10.1016/0731-7085(95)01644-9
P577
1996-02-01T00:00:00Z